We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitroso Oxcarbazepine EP Impurity D
N-Nitroso Oxcarbazepine EP Impurity D
CAT No SRC-N014756
CAS No NA
Mol.F. C14H8N2O3
Mol.Wt. 252.2
INV STATUS CUSTOM SYNTHESIS
Zanubrutinib Nitroso Impurity 1
Zanubrutinib Nitroso Impurity 1
CAT No SRC-N014757
CAS No NA
Mol.F. C24H26N6O3
Mol.Wt. 446.5
INV STATUS UNDER SYNTHESIS
Zanubrutinib Nitroso Impurity 2
Zanubrutinib Nitroso Impurity 2
CAT No SRC-N014758
CAS No NA
Mol.F. C24H26N6O3
Mol.Wt. 446.5
INV STATUS UNDER SYNTHESIS
N-Nitroso Zanubrutinib
N-Nitroso Zanubrutinib
CAT No SRC-N014759
CAS No NA
Mol.F. C27H28N6O4
Mol.Wt. 500.6
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Argatroban
N-Nitroso Argatroban
CAT No SRC-N014760
CAS No NA
Mol.F. C23H35N7O6S
Mol.Wt. 537.6
INV STATUS CUSTOM SYNTHESIS
Cariprazine Nitroso Impurity 1
Cariprazine Nitroso Impurity 1
CAT No SRC-N014761
CAS No 2221987-86-4
Mol.F. C10H12ClN3O
Mol.Wt. 225.7
INV STATUS IN STOCK
N-Nitroso Bisoprolol EP Impurity E
N-Nitroso Bisoprolol EP Impurity E
CAT No SRC-N014762
CAS No NA
Mol.F. C18H28N2O4
Mol.Wt. 336.4
INV STATUS UNDER SYNTHESIS
N-Nitroso Bisoprolol EP Impurity A
N-Nitroso Bisoprolol EP Impurity A
CAT No SRC-N014763
CAS No NA
Mol.F. C13H20N2O4
Mol.Wt. 268.3
INV STATUS IN STOCK
N-Nitroso Lanreotide
N-Nitroso Lanreotide
CAT No SRC-N014764
CAS No NA
Mol.F. C54H68N12O11S2
Mol.Wt. 1125.3
INV STATUS CUSTOM SYNTHESIS
N-Nitroso Ranolazine Impurity 2
N-Nitroso Ranolazine Impurity 2
CAT No SRC-N014765
CAS No NA
Mol.F. C14H20N4O2
Mol.Wt. 276.3
INV STATUS UNDER SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.